|
Volumn 9, Issue 2, 2012, Pages 149-152
|
Developments in the understanding and treatment of retinal disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFLIBERCEPT;
BEVACIZUMAB;
DEXAMETHASONE;
MALONALDEHYDE;
RANIBIZUMAB;
RAPAMYCIN;
VERTEPORFIN;
ACADEMIC ACHIEVEMENT;
CAREER PLANNING;
COMPLEMENT FACTOR H GENE;
DIABETIC RETINOPATHY;
DIET THERAPY;
DISEASE ASSOCIATION;
GENE;
GENE FREQUENCY;
HUMAN;
INTERMETHOD COMPARISON;
LIFESTYLE MODIFICATION;
MEDICAL EDUCATION;
MEDICAL RESEARCH;
MOLECULAR PATHOLOGY;
NOTE;
OUTCOME ASSESSMENT;
PHYSICIAN ATTITUDE;
PROCESS DEVELOPMENT;
PROFESSIONAL COMPETENCE;
PROFESSIONAL KNOWLEDGE;
PROFESSIONAL PRACTICE;
PROFESSIONALISM;
QUALITY OF LIFE;
RETINA DETACHMENT;
RETINA DISEASE;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA MACULA EDEMA;
RISK ASSESSMENT;
RISK FACTOR;
SCLERA BUCKLING PROCEDURE;
SYNDROME DELINEATION;
TREATMENT PLANNING;
UPREGULATION;
VITRECTOMY;
|
EID: 84858066591
PISSN: 20449038
EISSN: 20449046
Source Type: Journal
DOI: 10.2217/cpr.12.12 Document Type: Note |
Times cited : (1)
|
References (6)
|